Valuation: Omnicell, Inc.

Market Cap 1.72B 1.54B 1.41B 1.29B 2.42B 161B 2.5B 16.97B 6.77B 86.14B 6.45B 6.31B 272B P/E 2026 *
33.7x
P/E 2027 * 42x
Enterprise Value 1.72B 1.54B 1.41B 1.29B 2.42B 161B 2.5B 16.97B 6.77B 86.14B 6.45B 6.31B 272B EV / Sales 2026 *
1.4x
EV / Sales 2027 * 1.39x
Free-Float
76.56%
Yield 2026 *
-
Yield 2027 * -
1 day-1.81%
1 week+1.88%
Current month+1.88%
1 month+6.05%
3 months+1.44%
6 months-13.82%
Current year-17.57%
1 week 35.19
Extreme 35.19
40.1
1 month 35.07
Extreme 35.07
40.1
Current year 31.75
Extreme 31.75
55
1 year 31.75
Extreme 31.75
55
3 years 22.66
Extreme 22.66
55.74
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
17/8/26 Sell

Chairperson

-3,083 0.0068%
15/8/26 Tax

Chief Executive Officer

-12,350 0.0272%
15/8/26 Tax

Chief Administrative Officer

-4,025 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-1.81%+1.88%+4.65%+21.27% 1.72B
+2.63%-0.32%+21.37%+51.28% 257B
+1.73%-0.85%+9.67%+16.14% 162B
-3.36%+4.81%-19.14%+62.47% 157B
-4.23%+1.83%-57.26%-18.06% 61.96B
+1.31%+11.01%+22.48%+53.52% 58.73B
-0.76%+4.13%+3.16%-6.90% 55.42B
+1.73%-0.06%+19.09%+58.10% 49.27B
-2.05%-2.95%+3.01%+56.47% 49.18B
+1.00%-1.11%+23.11%+75.55% 44.96B
Average -0.38%+1.41%+3.02%+36.99% 89.76B
Weighted average by Cap. +0.25%+1.20%+4.62%+40.48%

Financials

2026 *2027 *
Net sales 1.23B 1.1B 1.01B 919M 1.73B 115B 1.79B 12.14B 4.84B 61.62B 4.61B 4.51B 195B 1.24B 1.11B 1.02B 928M 1.75B 117B 1.8B 12.25B 4.88B 62.19B 4.65B 4.55B 196B
Net income 51.55M 46.24M 42.26M 38.57M 72.68M 4.85B 74.97M 509M 203M 2.59B 194M 189M 8.16B 41.64M 37.35M 34.14M 31.16M 58.71M 3.91B 60.56M 411M 164M 2.09B 156M 153M 6.59B
Net Debt - -
Projected Income Statement - Annual - Omnicell, Inc.
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,450
Date Price Change Volume
06/11/26 US$37.34 -1.81% 562,787
05/11/26 US$38.03 -3.50% 783,367
04/11/26 US$39.41 +11.14% 850,497
03/11/26 US$35.46 -2.61% 890,827
02/11/26 US$36.41 -0.65% 1,078,692
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
MarketScreener Ratings - Omnicell, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
37.34USD
Average target price
57.43USD
Spread / Average Target
+53.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Omnicell, Inc.
  1. Stock Market
  2. Stocks
  3. OMCL Stock